Insiders Advicenne

Equities

ALDVI

FR0013296746

Market Closed - Euronext Paris Other stock markets 11:35:07 2024-07-12 am EDT			5-day change	1st Jan Change
2.04 ^EUR	0.00%		+2.51%	-23.31%

Apr. 08	Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 25	Advicenne: ODD designation in cystinuria	CF

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Advicenne S.A. Announces Executive Changes	22-06-10	CI
French Pharma Group Advicenne Chairman To Resign, Successor Named	22-04-22	MT
Advicenne Appoints Philippe Boucheron as Chairman of Its Board of Directors	22-04-21	CI
Advicenne Announces Executive Changes	21-05-03	CI
Advicenne Appoints Peter Meeus as Chief Executive Officer, Effective February 15, 2021	21-01-07	CI
Advicenne Appoints André Ulmann as Chief Medical Officer	21-01-07	CI
Advicenne Announces Management Changes	20-03-13	CI
Advicenne Announces Management Changes	18-09-25	CI
Advicenne Appoints Linda Law as US Vice President, Clinical Development and Medical Affairs	18-01-24	CI
Advicenne Appoints Ludovic Robin as Chief Business and Strategy Officer	16-09-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer